Intensive LDL Cholesterol Targeting Reduces Cardiovascular Events: Results from a Major RCT
A South Korean randomized trial demonstrated that lowering LDL cholesterol targets to <55 mg/dL significantly reduces cardiovascular events in patients with atherosclerotic cardiovascular disease compared to conventional targets. Intensive LDL reduction also showed a favorable safety profile, with l